Inventor · disambiguated record
Gerhard Max Gross
Also filed as: GROSS GERHARD · GROSS GERHARD MAX
8 granted patents·7 pending applications·8 citations·filing 2000–2020
76Inventor score
Files withJANSSEN PHARMACEUTICA NV6BIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACEUTICOS2BOERNSEN KLAUS OLAF2ABBOTT GMBH & CO KG1BORNSEN KLAUS OLAF1
Top patents by PatentIndex Score
15 records- 0168US7098214B1Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disordersABBOTT GMBH & CO KG·Filed 2000·Granted Aug 29, 2006·5 cites·7 claims
- 0265US7557105B2N-oxides of N-phenyl-2-pyrimidine-amine derivativesNOVARTIS AG·Filed 2003·Granted Jul 7, 2009·3 cites·5 claims
- 0359US11186589B2Cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 30, 2021·0 cites·20 claims
- 0459US2009239879A1N-oxides of n-phenyl-2-pyrimidine-amine derivativesBORNSEN KLAUS OLAF·Filed 2009·Application pending·0 cites
- 0554US2014323494A1N-oxides of n-phenyl-2-pyrimidine-amine derivativesBÖRNSEN KLAUS O·Filed 2014·Application pending·0 cites
- 0653US2019119299A1Cyanoindoline derivatives as nik inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 0748US11236084B2Substituted azaindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Feb 1, 2022·0 cites·15 claims
- 0845US2011294820A1N-Oxides of n-Phenyl-2-pyrimidine-amine DerivativesBOERNSEN KLAUS OLAF·Filed 2011·Application pending·0 cites
- 0945US2010222362A1N-oxides of n-phenyl-2-pyramidine-amine derivativesBOERNSEN KLAUS OLAF·Filed 2010·Application pending·0 cites
- 1039US11180487B2Substituted cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 23, 2021·0 cites·15 claims
- 1139US11136311B2Heteroaromatic derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 5, 2021·0 cites·15 claims
- 1239US11001569B26-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 11, 2021·0 cites·8 claims
- 1339US2003087917A1Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous systemFiled 2001·Application pending·0 cites
- 1437US10905738B2Synthetic peptides, prodrugs, pharmaceutical compositions and usesBIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACEUTICOS·Filed 2019·Granted Feb 2, 2021·0 cites·15 claims
- 1529US2021060125A1METHOD AND USE OF PnPP-19 FOR PREVENTING AND TREATING EYE DISEASESBIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACEUTICOS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gerhard Max Gross files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →